Search Results 231-240 of 18011 for progesterone

  1. Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer - Mayo Clinic

    The primary tumor must have been estrogen receptor (ER)-positive and/or progesterone receptor (PgR)-positive. (Patients who had a tumor that was considered ...

  2. A Study to Assess Kidney Function Markers in Transgender Individuals Receiving Gender-affirming Hormone Therapy - Mayo Clinic

    Participation eligibility · Individuals < 18 years of age. · Previous use of cross sex hormone therapy: Estrogen;; Testosterone;; Progesterone;; Spironolactone; ...

  3. Neurology - Clinical trials - Mayo Clinic

    ... progesterone receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable ...

  4. One of the largest male breast cancer studies to date illuminates state of treatment, prognosis and health disparities - Mayo Clinic

    Progesterone receptor-expressing tumors; Chemotherapy, radiation and anti-estrogen therapy; Residence in a high-income area. The correlation between total ...

  5. Clinical trials - Oncology (Medical)

    ... progesterone receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable ...

  6. Clinical trials - Oncology (Medical)

    ... progesterone receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable ...

  7. Clinical trials - Oncology (Medical)

    ... progesterone receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable ...

  8. Neurology - Clinical trials

    ... progesterone receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable ...

  9. Oncology (Medical) - Clinical trials

    ... progesterone receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable ...

  10. Clinical trials - Oncology (Medical)

    ... progesterone receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable ...